For the year ending 2024-12-31, ORGS made $1,035K in revenue. -$48,165K in net income. Net profit margin of -4653.62%.
| Income Statement | 2024-12-31 | |||
|---|---|---|---|---|
| Revenues | 1,035 | |||
| Cost of revenues | 1,928 | |||
| Gross loss | -893 | |||
| Impairment of investment | 0 | |||
| Cost of development services and research and development expenses | 9,622 | |||
| Amortization of intangible assets | 728 | |||
| Change in contingent consideration | -4,643 | |||
| Selling, general and administrative expenses included credit losses of 2,724 for the year ended december 31, 2024 and (24,367 for the year ended december 31, 2023) | 14,822 | |||
| Share in net loss of associated companies | -8 | |||
| Impairment of long-lived assets | 18,338 | |||
| Operating loss | -39,768 | |||
| Credit loss on convertible loan receivable | 0 | |||
| Loss (profit) from deconsolidation of obi, korea, belgium, services and octomera (see note 3 and note 20) | 4,480 | |||
| Other income, net | 606 | |||
| Loss from extinguishment in connection with loans | -5,422 | |||
| Financial expenses, net | -4,508 | |||
| Inducement expense on conversion of convertible loans | 4,304 | |||
| Loss before income taxes | -48,916 | |||
| Tax expense | 97 | |||
| Net loss | -49,013 | |||
| Net (loss) income attributable to non-controlling interests | -848 | |||
| Net loss attributable to orgenesis inc | -48,165 | |||
| Basic EPS | 11.44 | |||
| Diluted EPS | 11.44 | |||
| Basic Average Shares | 4,210,839 | |||
| Diluted Average Shares | 4,210,839 | |||
Orgenesis Inc. (ORGS)
Orgenesis Inc. (ORGS)